Top Industry Leaders in the Diabetes Devices Market
Latest Diabetes Devices Companies Update:
Abbott's acquisition of Dexcom in July 2023 has shaken the market, creating a diabetes care powerhouse with dominance in both continuous glucose monitoring (CGM) and blood glucose monitoring.
Insulet Corporation acquires Tandem Diabetes Care in September 2023, consolidating the insulin pump market and focusing on developing next-generation closed-loop systems.
Medtronic unveils the MiniMed 780G insulin pump, the first hybrid closed-loop system approved in the US, offering automated insulin adjustments based on CGM data.
Dexcom launches the G7 CGM system, featuring enhanced accuracy and extended sensor wear time, and plans to introduce a G7 model for non-insulin-dependent individuals in summer 2024.
Abbott introduces the FreeStyle Libre 3 sensor, boasting a thinner profile and integrated Bluetooth connectivity for seamless data transmission to smartphones.
List of Diabetes Devices Key companies in the market
- Abbott Laboratories
- Hoffmann-La-Ltd.
- Bayer AG
- Lifescan, Inc.
- B Braun Melsungen AG
- Dexcom Inc.
- Insulet Corporation
- Ypsomed Holdings
- Companion Medical
- Sanofi
- Valeritas Holding Inc
- Novo Nordisk
- Arkray, Inc.